Interferon alfa: effects of long-term treatment for polycythemia vera

Semin Hematol. 1997 Jan;34(1):40-50.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Interferon Type I / therapeutic use*
  • Male
  • Middle Aged
  • Polycythemia Vera / drug therapy*
  • Recombinant Proteins
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interferon Type I
  • Recombinant Proteins